| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7449ca99fbf1c556219fe28876cbf2a9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 |
| filingDate |
1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e8cace6f8f771b777c34bcedece434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9015fd42879557317b7bf8248fb5ced7 |
| publicationDate |
2000-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1012299-A2 |
| titleOfInvention |
Novel lipid kinase |
| abstract |
The invention relate to a novel human class II PI3-kinase and in particular the sequence of the isolated nucleic acid molecule and the encoded amino acid sequence. The novel human PI3-kinase is termed PI3K-C2α and has unique biochemical properties that characterise and distinguish it from known PI3-kinases. These include, amongst other things, resistance to the PI3-kinase inhibitors Wortmannin and LY294000, the lack of a p85 binding site, a divergent amino terminus and the absence of a polyproline motif which is typical of known type II PI3-kinases. |
| priorityDate |
1997-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |